First public showing of the 510(k)-cleared platform highlights real-time electromagnetic device tracking, advanced 3D visualization, and intraoperative imaging

IOPS Visionary represents an important advancement in how physicians visualize and navigate complex vascular anatomy. It offers a valuable new dimension of spatial orientation during EV procedures.”

— Michael Costanza, MD

CLEVELAND, OH, UNITED STATES, November 16, 2026 /EINPresswire.com/ — Centerline Biomedical, Inc. (“Centerline”), a medical technology company advancing image-guided endovascular navigation, will present the first public showing of its IOPS Visionary™ System at the 2026 VEITHsymposium, Booth 501, November 17–21, in New York City. The next generation of Centerline’s Intra-Operative Positioning System (IOPS) technology, Visionary brings together real-time electromagnetic navigation, patient-specific 3D vascular mapping, intraoperative imaging integration, and an enhanced physician interface in a modernized platform designed to advance navigation during complex endovascular procedures.

The debut marks an important milestone in the evolution of Centerline’s IOPS technology, introducing a new generation of capabilities designed to help physicians visualize and understand device position and orientation within complex three-dimensional vascular anatomy.

Bringing a New Dimension to Endovascular Navigation

Endovascular interventions are performed within intricate three-dimensional vascular anatomy, yet conventional fluoroscopy typically presents anatomical and device information through two-dimensional projections. IOPS provides an additional navigational perspective by displaying the real-time position and orientation of compatible sensor-equipped interventional devices within a patient-specific 3D vascular map.

IOPS Visionary builds on this foundation with enhanced visualization, expanded imaging integration, and intuitive physician controls designed to bring navigational information more directly into the procedural workflow.

Key advancements include:

• Enhanced 3D visualization
• Spintegration™ intraoperative 3D updates
• Live Fluoroscopic Overlay
• Direct tableside physician interaction
• Modernized system architecture

Together, these advancements extend the IOPS navigation environment by enabling physicians to incorporate additional imaging information as an intervention progresses, complementing conventional fluoroscopy with real-time spatial orientation.

First Public Showing at VEITHsymposium 2026

VEITHsymposium brings together vascular specialists and other healthcare professionals to discuss advances in the treatment of vascular disease. Centerline’s first public presentation of IOPS Visionary will provide the vascular community with an opportunity to learn about the platform’s capabilities and the evolution of the company’s approach to image-guided endovascular navigation.

“IOPS Visionary represents an important advancement in how physicians visualize and navigate complex vascular anatomy,” said Michael Costanza, MD, Chief, Division of Vascular Surgery and Endovascular Services, Upstate University Hospital, Syracuse, NY. “By providing real-time device positioning within a patient-specific 3D environment, together with updated intraoperative imaging information, the system offers a valuable new dimension of spatial orientation during endovascular procedures. As we continue to evaluate the clinical applications of this technology, one particularly promising area is its potential to reduce fluoroscopy utilization and associated radiation exposure during lengthy, complex interventions.”

Vikash Goel, Centerline’s Founder and Chief Technology Officer, remarked on the importance of this product debut. “Unveiling IOPS Visionary at the VEITHsymposium will give the vascular surgery community the chance to see firsthand our vision for the future of endovascular image guidance. Our mission has always been to provide a novel form of image guidance that allows physicians to appreciate 3D orientation of the devices they navigate through complex anatomy.

The next-generation system we are introducing now is the result of taking feedback from the field to heart. IOPS Visionary brings the IOPS platform to the next level by integrating more tightly into imaging suites, allowing the physician more direct control over visualization, and overall making for a more streamlined and intuitive experience.”

About Centerline Biomedical

Centerline Biomedical, Inc. is a medical technology company focused on advancing image-guided endovascular navigation. Its IOPS technology combines electromagnetic device tracking with patient-specific 3D vascular visualization to provide physicians with complementary spatial information during endovascular procedures. Through continued innovation in navigation, visualization, and imaging integration, Centerline is working to advance how physicians interact with and navigate complex vascular anatomy.

Designed to advance how physicians visualize, interact with, and navigate within complex vascular anatomy, the IOPS Visionary system introduces a substantially modernized platform that brings together real-time electromagnetic navigation, patient-specific 3D vascular mapping, interactive imaging integration, and an enhanced physician experience.

Centerline continues to invest in the development of its IOPS platform to further enhance its capabilities and expand image-guidance applications across transcatheter procedures.

About VEITHsymposium

Now in its 53rd year, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world-renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques. More information is available at www.VEITHsymposium.org.

Centerline Biomedical, the Centerline Logo, IOPS, and IOPS Visionary trademarks or registered trademarks of Centerline Biomedical. Any unauthorized use is expressly prohibited.

Merle Adelman
Adelman Associates
7818010507 ext.
merle.adelman@adelmanassociates.com
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Media gallery

About The Author